-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RVRwFqqJey96MDd5FqA52NNvf6jgL1xnSIG/3HNTtn6tz382adYKwzmLTngnwEEj v+8oLlvE7j3bqJugJZ99fA== 0000947871-01-000161.txt : 20010327 0000947871-01-000161.hdr.sgml : 20010327 ACCESSION NUMBER: 0000947871-01-000161 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20010316 FILED AS OF DATE: 20010326 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: AMERISOURCE HEALTH CORP/DE CENTRAL INDEX KEY: 0000855042 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122] IRS NUMBER: 232546940 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 3 SEC ACT: SEC FILE NUMBER: 000-20485 FILM NUMBER: 1579465 BUSINESS ADDRESS: STREET 1: PO BOX 959 CITY: VALLEY FORGE STATE: PA ZIP: 19482 BUSINESS PHONE: 6102964480 MAIL ADDRESS: STREET 1: 300 CHESTER FIELD PKWY CITY: MALVERN STATE: PA ZIP: 19355 FORMER COMPANY: FORMER CONFORMED NAME: AMERISOURCE DISTRIBUTION CORP DATE OF NAME CHANGE: 19940811 FORMER COMPANY: FORMER CONFORMED NAME: ALCO HEALTH DISTRIBUTION CORP /DE/ DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: AHSC HOLDINGS CORP DATE OF NAME CHANGE: 19920325 COMPANY DATA: COMPANY CONFORMED NAME: BERGEN BRUNSWIG CORP CENTRAL INDEX KEY: 0000011454 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122] OWNER IRS NUMBER: 221444512 STATE OF INCORPORATION: NJ FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 3 BUSINESS ADDRESS: STREET 1: 4000 METROPOLITAN DR CITY: ORANGE STATE: CA ZIP: 92668 BUSINESS PHONE: 7143854000 MAIL ADDRESS: STREET 1: 4000 METROPOLITAN DRIVE CITY: ORANGE STATE: CA ZIP: 92668 FORMER COMPANY: FORMER CONFORMED NAME: BERGEN DRUG CO INC DATE OF NAME CHANGE: 19690409 3 1 0001.txt FORM 3
- ---------------- U.S. SECURITIES AND EXCHANGE COMMISSION |F O R M 3| Washington D.C. 20549 OMB APPROVAL - ---------------- -------------------------------- INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES OMB Number 3235-0104 Expires: December 31, 2001 Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Estimated average burden Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 hours per response . . . .0.5 -------------------------------- - ------------------------------------------------------------------------------------------------------------------------------------ |1.Name and Address of Reporting Person* |2.Date of Event Requiring|4.Issuer Name and Ticker or Trading Symbol | | | Statement for | | | Bergen Brunswig Corporation | (Month/Day/Year) | | | | 03/16/01 | AmeriSource Health Corporation (AAS) | |----------------------------------------|------------------------------------------------------------------------------------------ | (Last) (First) (MI) |3.IRS or Social Security |5.Relationship of Reporting Persons|6.If Amendment, Date of | | | Number of Reporting | to Issuer | Original (Month/Day/Year)| | | Person (Voluntary) | (Check all applicable) | | | 4000 Metropolitan Drive | | ___ Director _X_ 10% Owner |---------------------------| | | | ___ Officer ___ Other |7.Individual or Joint/Group| |----------------------------------------| | (give title (specify below) | Filing | | (Street) | 22-1444512 | below) | (Check applicable line) | | | | | X Form filed by One | | | | | Reporting Person | | | | ________________________ | __Form filed by More than| | Orange California 92868-3510 | | | One Reporting Person | |----------------------------------------|-----------------------------------------------------------------------------------------| | (City) (State) (Zip) | | | | TABLE I - Non-Derivative Securities Beneficially Owned | | *If the Form is filed by more than one| | | Reporting Person, see Instructions | | | 5(b)(v) | | |----------------------------------------------------------------------------------------------------------------------------------| |1.Title of Security |2. Amount of Securities|3. Ownership Form: |4. Nature of Indirect Beneficial Ownership| | (Instr. 4) | Beneficially Owned | Direct (D) of | (Instr. 5) | | | (Instr. 4) | Indirect (I) | | | | | (Instr. 5) | | |----------------------------------------------------------------------------------------------------------------------------------| | | | | | | | | | | - ------------------------------------------------------------------------------------------------------------------------------------ Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. (Over) (Print or Type Responses)
FORM 3 (continued) TABLE II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) - ----------------------------------------------------------------------------------------------------------------------------------- |1.Title of Derivative Security |2.Date Exercisable |3.Title and Amount of Securities |4.Conversion |5.Ownership |6.Nature of | | (Instr. 4) | and Expiration | Underlying Derivative Security | or Exercise| Form of | Indirect | | | Date (Month | (Instr. 4) | Price of | Derivative | Beneficial| | | Day Year) | | Derivative | Security: | Ownership | | |--------------------------------------------------------| Security | Direct (D) | (Instr. 5)| | |Date |Expiration| |Amount or | | or Indirect| | | |Exercis-|Date | Title |Number of | | (I) | | | |able | | |Shares | | (Instr. 5) | | |----------------------------------------------------------------------------------------------------------------------------------| | | | | | | | | | | Option to Purchase Class A | | |Class A Common Stock, |10,472,304| $48.48 | D | | | Common Stock | (1) | (1) |per value $0.01 per share| | | | | |----------------------------------------------------------------------------------------------------------------------------------| | | | | | | | | | | | | | | | | | | - ----------------------------------------------------------------------------------------------------------------------------------- Explanation of Responses: (1) On March 16, 2001, Bergen Brunswig Corporation ("Bergen"), AmeriSource Health Corporation (the "Issuer"), AABB Corporation, a Delaware corporation, A-Sub Acquisition Corp., a Delaware corporation, and B-Sub Acquisition Corp., a New Jersey corporation, entered into an Agreement and Plan of Merger (the "Merger Agreement"). In connection with the Merger Agreement, Bergen and the Issuer entered into a Stock Option Agreement pursuant to which the Issuer granted to Bergen an option (the "Option") to purchase up to 10,472,304 shares (the "Option Shares") of the Issuer's Class A Common Stock representing approximately 19.9% of the outstanding Issuer Common Stock issued and outstanding as of March 15, 2001. The Option has an exercise price of $48.48 per share, payable in cash. The Option may be exercised by Bergen at any time during the 180-day period after Bergen becomes entitled to receive a termination fee from the Issuer under Section 8.5(c)(i) of the Merger Agreement (a "Purchase Event"). If no Purchase Event occurs, the Stock Option Agreement will terminate generally upon the earlier of (1) the effective time of the Merger or (2) the termination of the Merger Agreement. The Option is not presently exercisable, and Bergen expressly disclaims beneficial ownership of any of the Option Shares until such time as Bergen purchases such shares upon exercise of the Option. Also in connection with the Merger Agreement, certain shareholders who are executive officers and directors of the Issuer (the "Shareholders"), entered into Support/Voting Agreements with Bergen with respect to an aggregate of 1,262,700 shares (which includes options to purchase shares) of Issuer Common Stock beneficially owned by them (the "Shares"). Pursuant to such agreements, the Shareholders have agreed, among other things, to vote the Shares in favor of the Merger. The shares of Issuer Common Stock covered by the Support/Voting Agreements are not included in this Initial Statement on Form 3 because Bergen has no pecuniary interest in such shares and Bergen expressly disclaims any beneficial ownership thereof. References to, and descriptions of, the merger, the Merger Agreement, the Stock Option Agreement and the Support/Voting Agreements as set forth herein are qualified in their entirety by reference to (i) the Merger Agreement, which is filed as Exhibit 2.1 to the Bergen Form 8-K, filed on March 19, 2001, (ii) the Stock Option Agreement which is filed as Exhibit 2 to the Bergen Schedule 13D filed on the date hereof and (iii) the Support/Voting Agreements which are filed as Exhibits 3 and 4 to the Bergen Schedule 13D filed on the date hereof. Bergen Brunswig Corporation **Intentional misstatements or omissions of facts constitute Federal 3/26/01 Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). ------------------------------------------ ----------- **Signature of Reporting Person Date Note: File three copies of this Form, one of which must be manually signed. Name: Milan A. Sawdei If space provided is insufficient, see Instruction 6 for procedure. Title: Executive Vice President, Chief Legal Officer and Secretary Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a current valid OMB Number.
-----END PRIVACY-ENHANCED MESSAGE-----